The hospital is a joint venture between UnityPoint Health – Trinity and Encompass Health
BIRMINGHAM, Ala. and MOLINE, Ill. , Aug. 23, 2022 /PRNewswire/ -- UnityPoint Health – Trinity and Encompass Health (NYSE: EHC) announce the opening of Quad Cities Rehabilitation Institute, a 40-bed inpatient rehabilitation hospital located at 653 52nd Avenue in Moline, Illinois . The hospital serves patients recovering from debilitating injuries and illnesses, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions.
In addition to 24-hour nursing care, Quad Cities Rehabilitation Institute will offer physical, occupational and speech therapies to restore functional ability and quality of life. Care is provided by highly specialized nurses, therapists and physicians. The hospital features all private patient rooms, a large therapy gym with advanced rehabilitation technologies, an activities of daily living suite, and an on-site dialysis suite.
"We are excited to open this hospital in Moline as a joint venture between Encompass Health, a national leader in post-acute healthcare services, and UnityPoint Health, an industry leader in the Midwest," said Tammy Pauwels , CEO of Quad Cities Rehabilitation Institute. "As the region's only freestanding inpatient rehabilitation hospital, we will provide essential services to help patients regain function and independence as they recover from major injuries and illnesses. Both UnityPoint Health and Encompass Health have a proven track record of quality, patient and family satisfaction and are united in our mission to providing compassionate care."
The Quad Cities Rehabilitation Institute is Encompass Health's 152nd inpatient rehabilitation hospital, and its fourth location in Illinois .
About UnityPoint Health UnityPoint Health is the nation's 13th largest nonprofit health system and the fourth largest nondenominational health system in America, providing care throughout Iowa , western Illinois and southern Wisconsin . As an industry leader in the Midwest, we put people first — they're our sweet spot, what we care about most, and why we do what we do. Our 30,000 team members are committed to giving each person the type of experience we'd want for our own loved ones. We believe everyday moments are worth celebrating, and as your partner in health care, we're dedicated to making it easier to live well. UnityPoint Health, UnityPoint Clinic® and UnityPoint at HomeSM provide easier, more personal care to patients and families. Because people are amazing, and we're here to help keep them that way.
About Encompass Health Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States . With a national footprint that includes 152 hospitals in 36 states and Puerto Rico , the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's 100 Best Companies to Work For and Modern Healthcare's Best Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.
Encompass Health Media Contact:
UnityPoint Health – Trinity Media Contact:
Danielle Hall | 205-970-5912
Kristy Phillipson | 309-373-3839
danielle.hall@encompasshealth.com
Kristy.phillipson@unitypoint.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/quad-cities-rehabilitation-institute-a-40-bed-inpatient-rehabilitation-hospital-now-open-in-moline-illinois-301610944.html
Stéphane Bancel discusses the company’s latest Covid shot and prospects for using mRNA in seasonal flu vaccines and personalized treatments for cancer
Investors have lost patience with the slow-paced clinical trials of genetic therapies, and some are using the upbeat news to exit Intellia and peers.
A San Francisco-based immunology company that wants to help eradicate infectious disease globally has expanded its footprint in St. Louis, opening a new $41 million office within the Cortex innovation district. It says the new facility will be critical to advancing research to treat several infectious diseases, including Covid-19.
Intellia said Friday it knocked out the gene responsible for a rare and deadly swelling disorder. But CRISPR stocks sank.
In a recent interview with PEOPLE, the couple, whose real-life love story was portrayed in The Big Sick, opened up about what it's like to be in the immunocompromised community
Regeneron (REGN) and its partner Alnylam announce promising data from its ongoing phase I study evaluating ALN-HSD in healthy adults and NASH patients.
In that spirit, let's examine two healthcare stocks that seem to have the tools to provide solid returns over the long term: Eli Lilly (NYSE: LLY) and Teladoc Health (NYSE: TDOC). Eli Lilly seems to excel in both areas. Take one of the company's most recent approvals: Mounjaro, a therapy used to control blood glucose levels in patients with type 2 diabetes.
A labor shortage at a pharmaceutical company along with increased demand left Adderall on back-order at many pharmacies across the country.
J&J (JNJ) announces a new $5 billion stock buyback plan. CHMP recommends authorizing Pfizer's (PFE) Omicron BA.4 and BA.5 boosters in Europe.
Intellia Therapeutics said two of its experimental Crispr treatments produced positive results in early-stage trials.
Gilead Sciences Inc (NASDAQ: GILD) announced updates to the World Health Organization's (WHO) Therapeutics and COVID-19: living guideline, which now conditionally recommends Veklury (remdesivir) for severe COVID-19. WHO continues to conditionally recommend Veklury in those with non-severe COVID-19 at the highest risk of hospitalization. The WHO conditional recommendation is mainly driven by the final results of the WHO-sponsored SOLIDARITY study, which showed a statistically significant 17% lowe
The following two healthcare stocks look like great buys for investors seeking to collect both above-average income and increase wealth. The good news for cancer patients is that Merck's (NYSE: MRK) cancer drug called Keytruda is approved in the U.S. to treat 19 different forms of the disease. Looking out over the long term, Merck's pipeline is just as strong as its existing products.
As the bear market emerged, even some of the healthiest companies saw their shares drop or stagnate. Shares of Axsome Therapeutics (NASDAQ: AXSM) have climbed 64% this year. Most of the gains came in recent weeks after the company's great news: It won U.S. regulatory approval for Auvelity, its drug for major depressive disorder (MDD).
A surgery to remove the problem tissue went "extremely well," her doctor said.
How do you fix a forgetful memory? Neurologist shares brain exercises to keep memory sharp, including reading fiction, cooking from recipes and playing games.
Gilead's (GILD) Veklury is now recommended by the WHO for use in both non-severe COVID-19 patients at the highest risk of hospitalization and those with severe COVID-19.
In June, a Dallas area doctor who was feeling unwell wanted to use a saline IV bag she had gotten from her work to try to rehydrate. She tapped it into her veins while at home. Minutes later, she suffered a major medical event and died, court records say. Now, Raynaldo Rivera Ortiz Jr., an anesthesiologist at her surgical facility, faces federal charges for allegedly tampering with IV bags in a way that resulted in the death of his colleague as well as several other cardiac emergencies, accordin
“The safety of the nation’s pharmaceutical supply is critically important,” said Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Justice Department’s Civil Division
Lawmakers hear from scientists about advancements to slow down the aging process
Eloxx Pharmaceuticals' (ELOX) phase II combination study evaluating pipeline candidate ELX-02 in cystic fibrosis fails to achieve statistical significance in efficacy endpoints.